Horan Capital Advisors, Llc. Abbott Laboratories Transaction History

Horan Capital Advisors, Llc.

$298 Million
Q3 2024

A detailed history of Horan Capital Advisors, Llc. transactions in Abbott Laboratories stock. As of the latest transaction made, Horan Capital Advisors, Llc. holds 32,187 shares of ABT stock, worth $3.68 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

32,187

Previous 32,481 0.91%

Holding current value

$3.68 Million

Previous $3.38 Million 8.71%

% of portfolio

1.23%

Previous 1.19%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$100.07 - $118.13 $29,420 - $34,730	-294 Reduced 0.91%	32,187 $3.67 Million
Q2 2024 Aug 06, 2024	BUY	$100.73 - $112.44 $4,029 - $4,497	40 Added 0.12%	32,481 $3.38 Million
Q1 2024 May 01, 2024	SELL	$109.52 - $120.96 $45,012 - $49,714	-411 Reduced 1.25%	32,441 $3.69 Million
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $33,009 - $40,406	-366 Reduced 1.1%	32,852 $3.62 Million
Q3 2023 Nov 01, 2023	SELL	$95.53 - $114.62 $93,428 - $112,098	-978 Reduced 2.86%	33,218 $3.22 Million
Q2 2023 Aug 01, 2023	BUY	$100.78 - $112.29 $16,527 - $18,415	164 Added 0.48%	34,196 $3.73 Million
Q1 2023 May 01, 2023	BUY	$96.86 - $114.01 $67,511 - $79,464	697 Added 2.09%	34,032 $3.45 Million
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $9,506 - $11,152	100 Added 0.3%	33,335 $3.66 Million
Q3 2022 Nov 01, 2022	BUY	$96.76 - $112.03 $97,534 - $112,926	1,008 Added 3.13%	33,235 $3.22 Million
Q2 2022 Aug 10, 2022	BUY	$102.07 - $123.37 $32,049 - $38,738	314 Added 0.98%	32,227 $3.5 Million
Q1 2022 May 03, 2022	BUY	$114.02 - $139.04 $88,137 - $107,477	773 Added 2.48%	31,913 $3.78 Million
Q4 2021 Feb 01, 2022	BUY	$115.53 - $141.46 $108,713 - $133,113	941 Added 3.12%	31,140 $4.38 Million
Q3 2021 Nov 08, 2021	BUY	$116.66 - $129.06 $72,329 - $80,017	620 Added 2.1%	30,199 $3.57 Million
Q2 2021 Aug 05, 2021	BUY	$105.79 - $124.53 $114,782 - $135,115	1,085 Added 3.81%	29,579 $3.43 Million
Q1 2021 May 05, 2021	BUY	$108.84 - $128.23 $55,290 - $65,140	508 Added 1.82%	28,494 $3.42 Million
Q4 2020 Feb 02, 2021	BUY	$105.0 - $114.42 $104,685 - $114,076	997 Added 3.69%	27,986 $3.06 Million
Q3 2020 Nov 04, 2020	BUY	$91.64 - $111.29 $18,053 - $21,924	197 Added 0.74%	26,989 $2.94 Million
Q2 2020 Aug 03, 2020	SELL	$76.57 - $98.0 $31,010 - $39,690	-405 Reduced 1.49%	26,792 $2.45 Million
Q1 2020 Apr 29, 2020	BUY	$62.82 - $91.86 $691 - $1,010	11 Added 0.04%	27,197 $2.15 Million
Q4 2019 Feb 05, 2020	SELL	$78.51 - $87.4 $31,561 - $35,134	-402 Reduced 1.46%	27,186 $2.36 Million
Q3 2019 Oct 22, 2019	SELL	$81.84 - $88.74 $10,639 - $11,536	-130 Reduced 0.47%	27,588 $2.31 Million
Q2 2019 Jul 26, 2019	SELL	$72.88 - $85.0 $91,464 - $106,675	-1,255 Reduced 4.33%	27,718 $2.33 Million
Q1 2019 Apr 22, 2019	SELL	$66.22 - $80.06 $286,798 - $346,739	-4,331 Reduced 13.0%	28,973 $2.32 Million
Q4 2018 Feb 04, 2019	BUY	$65.56 - $74.27 $17,045 - $19,310	260 Added 0.79%	33,304 $2.41 Million
Q3 2018 Nov 02, 2018	SELL	$60.81 - $73.36 $39,404 - $47,537	-648 Reduced 1.92%	33,044 $2.42 Million
Q2 2018 Sep 13, 2018	BUY	$57.57 - $63.54 $1.94 Million - $2.14 Million	33,692 New	33,692 $2.06 Million
Q2 2018 Jul 31, 2018	SELL	$57.57 - $63.54 $2.76 Million - $3.04 Million	-47,857 Closed	0 $0
Q1 2018 Apr 23, 2018	BUY	$56.27 - $63.62 $32,242 - $36,454	573 Added 1.21%	47,857 $2.87 Million
Q4 2017 Feb 06, 2018	SELL	$53.68 - $57.47 $143,594 - $153,732	-2,675 Reduced 5.35%	47,284 $2.7 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $2.4 Million - $2.68 Million	49,959	49,959 $2.67 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Horan Capital Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Horan Capital Advisors, Llc. with notifications on news.

Account

Horan Capital Advisors, Llc. Abbott Laboratories Transaction History